Borresen-Dale AL - Search Results

1

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al. Phelan CM, et al. Cancer Res. 1998 Mar 1;58(5):1004-12. Cancer Res. 1998. PMID: 9500463

2

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Laake K, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):175-80. Genes Chromosomes Cancer. 1997. PMID: 9071570

3

Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation.

Zelada-Hedman M, Børresen-Dale AL, Lindblom A. Zelada-Hedman M, et al. Hum Mutat. 1997;9(3):289. doi: 10.1002/(SICI)1098-1004(1997)9:3<289::AID-HUMU15>3.0.CO;2-Z. Hum Mutat. 1997. PMID: 9090537 No abstract available.

4

Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.

Zelada-Hedman M, Børresen-Dale AL, Claro A, Chen J, Skoog L, Lindblom A. Zelada-Hedman M, et al. Br J Cancer. 1997;75(8):1201-4. doi: 10.1038/bjc.1997.205. Br J Cancer. 1997. PMID: 9099970 Free PMC article.

5

A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region.

Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Håkansson S, Andersen TI, Borg A, Børresen Dale AL, Lindblom A. Zelada-Hedman M, et al. Cancer Res. 1997 Jun 15;57(12):2474-7. Cancer Res. 1997. PMID: 9192828

6

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. Kristensen VN, et al. Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006. Pharmacogenetics. 1998. PMID: 9511180

7

Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases.

Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL. Sørlie T, et al. Breast Cancer Res Treat. 1998 Apr;48(3):259-64. doi: 10.1023/a:1005953519972. Breast Cancer Res Treat. 1998. PMID: 9598872

8

Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.

Adélaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Børresen-Dale AL, Lidereau R, Birnbaum D, Pébusque MJ. Adélaïde J, et al. Genes Chromosomes Cancer. 1998 Jul;22(3):186-99. doi: 10.1002/(sici)1098-2264(199807)22:3<186::aid-gcc4>3.0.co;2-s. Genes Chromosomes Cancer. 1998. PMID: 9624530

9

The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.

Lothe RA, Hektoen M, Johnsen H, Meling GI, Andersen TI, Rognum TO, Lindblom A, Børresen-Dale AL. Lothe RA, et al. Cancer Res. 1998 Jul 15;58(14):2923-4. Cancer Res. 1998. PMID: 9679946

10

[Diagnostic molecular biology in breast cancer].

Andersen TI, Børresen-Dale AL. Andersen TI, et al. Tidsskr Nor Laegeforen. 1998 Jun 10;118(15):2366-9. Tidsskr Nor Laegeforen. 1998. PMID: 9691806 Review. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters